Pazopanib Interactions
There are 706 drugs known to interact with pazopanib, along with 11 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 170 are major, 519 are moderate, and 17 are minor.
- View all 706 medications that may interact with pazopanib
- View pazopanib alcohol/food interactions (1)
- View pazopanib disease interactions (11)
Most frequently checked interactions
View interaction reports for pazopanib and the medicines listed below.
- Afinitor (everolimus)
- Alcohol (contained in alcoholic beverages) (ethanol)
- Ativan (lorazepam)
- Cardizem CD (diltiazem)
- Coenzyme Q10 (ubiquinone)
- Combivent (albuterol / ipratropium)
- Compazine (prochlorperazine)
- Crestor (rosuvastatin)
- Fleet Enema (sodium biphosphate / sodium phosphate)
- Flomax (tamsulosin)
- Fosamax (alendronate)
- Keppra (levetiracetam)
- Lasix (furosemide)
- Lipitor (atorvastatin)
- Lovenox (enoxaparin)
- Lyrica (pregabalin)
- Metoprolol Succinate ER (metoprolol)
- Morphine Sulfate ER (morphine)
- Nexavar (sorafenib)
- Paracetamol (acetaminophen)
- Prilosec (omeprazole)
- Quercetin (bioflavonoids)
- Reglan (metoclopramide)
- Retinol (vitamin a topical)
- Singulair (montelukast)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin D3 (cholecalciferol)
- Vitamin K2 (menaquinone)
- Zofran (ondansetron)
Pazopanib alcohol/food interactions
There is 1 alcohol/food interaction with pazopanib.
Pazopanib disease interactions
There are 11 disease interactions with pazopanib which include:
- bleeding
- liver dysfunction
- GI perforation
- CV disease
- hypothyroidism
- lung dysfunction
- QT prolongation
- hypertension
- PRES
- proteinuria
- thromboembolic disorders
Report options
More about pazopanib
- pazopanib consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (92)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: VEGF/VEGFR inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Votrient
Votrient is used to treat renal cell carcinoma (kidney cancer). Learn about side effects ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Yondelis
Yondelis (trabectedin) is used to treat liposarcoma or leiomyosarcoma, two common subtypes of soft ...
Tecentriq
Tecentriq (atezolizumab) is a monoclonal antibody used to treat non-small cell lung cancer, small ...
Tecentriq Hybreza
Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) is a subcutaneous formulation of Tecentriq ...
Atezolizumab/hyaluronidase
Atezolizumab/hyaluronidase is used for alveolar soft part sarcoma, hepatocellular carcinoma ...
Atezolizumab
Atezolizumab (Tecentriq) is a type of immunotherapy drug that helps the body's immune system to ...
Doxorubicin
Doxorubicin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
